Mucopolysaccharidoses (MPS) are lysosomal storage diseases that result from defective metabolism of complex carbohydrates. The accumulation of mucopolysaccharides manifests as neurologic and somatic diseases. The diseases are clinically heterogeneous but have many shared neurologic sequelae. Neuroradiographic techniques have evolved such that correlation with known neuropathologic findings can now be achieved during the MPS patient's life. These techniques allow assessment of possibly beneficial therapies.
|Original language||English (US)|
|Number of pages||13|
|Journal||Neuroimaging Clinics of North America|
|State||Published - Jan 1 1993|
ASJC Scopus subject areas
- Radiology Nuclear Medicine and imaging
- Clinical Neurology